Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Norway
Biotech
BerGenBio, following lead drug's failure, merges with Oncoinvent
BerGenBio, reeling from the failure of its lead cancer drug, has opted to merge with fellow Norwegian cancer biotech Oncoinvent.
James Waldron
Jul 1, 2025 7:00am
Nordic Nanovector board members jump ship
Sep 16, 2022 9:15am
AstraZeneca success torpedoes PCI's pivotal plan, crushing stock
Jan 25, 2022 7:30am
Nykode, celebrates new name with Regeneron deal
Nov 23, 2021 7:35am
TAK1 blocker teams up with chemo to kill myeloma cells: study
Oct 18, 2021 10:00am
Targovax nabs Roche veteran as CSO
Apr 30, 2020 8:45am
